標(biāo)題: Titlebook: ; [打印本頁] 作者: invoke 時(shí)間: 2025-3-21 18:52
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis影響因子(影響力)
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis影響因子(影響力)學(xué)科排名
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis網(wǎng)絡(luò)公開度
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis被引頻次
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis被引頻次學(xué)科排名
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis年度引用
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis年度引用學(xué)科排名
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis讀者反饋
書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis讀者反饋學(xué)科排名
作者: Foam-Cells 時(shí)間: 2025-3-21 23:54
Diseases that Mimic Idiopathic Pulmonary Fibrosis,There are number of conditions that may commonly be confused and difficult to differentiate from idiopathic pulmonary fibrosis (IPF). This chapter discusses these conditions in more detail.作者: Arthropathy 時(shí)間: 2025-3-22 02:45 作者: Badger 時(shí)間: 2025-3-22 08:14 作者: 無意 時(shí)間: 2025-3-22 09:06
https://doi.org/10.1007/978-3-642-28708-4. There are two agents that have been shown to slow the rate of deterioration in lung function in IPF. These two drugs, pirfenidone and nintedanib, have been variably approved in countries around the world.作者: Spina-Bifida 時(shí)間: 2025-3-22 14:31 作者: Spina-Bifida 時(shí)間: 2025-3-22 21:08 作者: 極少 時(shí)間: 2025-3-23 00:56
Treatment of Idiopathic Pulmonary Fibrosis,. There are two agents that have been shown to slow the rate of deterioration in lung function in IPF. These two drugs, pirfenidone and nintedanib, have been variably approved in countries around the world.作者: 無聊的人 時(shí)間: 2025-3-23 02:09 作者: 鑒賞家 時(shí)間: 2025-3-23 08:08
Clinical Presentation and Diagnosis,are more likely to notice the onset of their symptoms sooner compared to those patients who are more sedentary. Given the non-specific symptoms of idiopathic pulmonary fibrosis (IPF), patients are frequently misdiagnosed initially. Non-specific symptoms include:作者: 劇本 時(shí)間: 2025-3-23 12:45
Pathogenesis of Idiopathic Pulmonary Fibrosis, genetically susceptible host [1]. The initial injury appears to be to the alveolar epithelial cells (AECs), particularly type II AECs. The current understanding of the pathogenesis of IPF is depicted in Fig. 4.1.作者: 額外的事 時(shí)間: 2025-3-23 15:51 作者: 行為 時(shí)間: 2025-3-23 19:37 作者: Apoptosis 時(shí)間: 2025-3-23 22:41
Six Lectures on Modern Natural Philosophyends to be progressive in nature, and results in significant morbidity and mortality. IPF needs to be differentiated from the many other causes ILDs. Table 1.1 categorizes all the ILDs by a simple mnemonic of five ‘I’s, a ‘C’, and an ‘N’ [1].作者: compassion 時(shí)間: 2025-3-24 03:43
Six Lectures on Plotinus and Gnosticismare more likely to notice the onset of their symptoms sooner compared to those patients who are more sedentary. Given the non-specific symptoms of idiopathic pulmonary fibrosis (IPF), patients are frequently misdiagnosed initially. Non-specific symptoms include:作者: Triglyceride 時(shí)間: 2025-3-24 07:32 作者: BRUNT 時(shí)間: 2025-3-24 13:48 作者: 好開玩笑 時(shí)間: 2025-3-24 18:14
Six Lectures on Plotinus and Gnosticismting symptom in approximately 12?% of patients [1]. Patients who are physically more active and robust in their daily lives or who exercise regularly are more likely to notice the onset of their symptoms sooner compared to those patients who are more sedentary. Given the non-specific symptoms of idi作者: 畢業(yè)典禮 時(shí)間: 2025-3-24 19:16
Representative: The Elected Path,inflammation, leading to fibrosis. The current understanding is based on the concept of repetitive injury with an abnormal wound healing response in a genetically susceptible host [1]. The initial injury appears to be to the alveolar epithelial cells (AECs), particularly type II AECs. The current un作者: 沙發(fā) 時(shí)間: 2025-3-24 23:43 作者: 憤怒事實(shí) 時(shí)間: 2025-3-25 04:33 作者: subacute 時(shí)間: 2025-3-25 09:40
https://doi.org/10.1007/978-3-642-28708-4. There are two agents that have been shown to slow the rate of deterioration in lung function in IPF. These two drugs, pirfenidone and nintedanib, have been variably approved in countries around the world.作者: PATRI 時(shí)間: 2025-3-25 12:46
https://doi.org/10.1007/978-3-540-85138-7oms and quality of life. However, there is no data to show that supplemental oxygen improves survival, although it can improve exercise capacity [1, 2]. Towards the late stages of IPF, high-flow oxygen devices such as an oxymizer or high humidity high-flow nasal cannula may be needed to maintain ade作者: 簡潔 時(shí)間: 2025-3-25 16:05
https://doi.org/10.1007/978-3-030-96213-5of writing, there were 107 open and enrolling studies involving IPF diagnosis and treatment listed on .. Future discoveries are bound to occur at the genomic level, providing a clearer understanding of single nucleotide polymorphisms (SNPs) that predispose to the disease or predetermine the course i作者: 獨(dú)特性 時(shí)間: 2025-3-25 22:26
Overview of Idiopathic Pulmonary Fibrosis,nary fibrosis (IPF) is a distinct subtype and one of the most common forms of ILD. It is a chronic fibrosing condition that is limited to the lungs, tends to be progressive in nature, and results in significant morbidity and mortality. IPF needs to be differentiated from the many other causes ILDs. 作者: 平 時(shí)間: 2025-3-26 00:49 作者: 權(quán)宜之計(jì) 時(shí)間: 2025-3-26 08:00 作者: 毛細(xì)血管 時(shí)間: 2025-3-26 10:53 作者: FEMUR 時(shí)間: 2025-3-26 13:24 作者: 戰(zhàn)勝 時(shí)間: 2025-3-26 16:58
Treatment of Idiopathic Pulmonary Fibrosis,. There are two agents that have been shown to slow the rate of deterioration in lung function in IPF. These two drugs, pirfenidone and nintedanib, have been variably approved in countries around the world.作者: VOK 時(shí)間: 2025-3-26 23:56
Non-pharmacologic Management of Idiopathic Pulmonary Fibrosis,oms and quality of life. However, there is no data to show that supplemental oxygen improves survival, although it can improve exercise capacity [1, 2]. Towards the late stages of IPF, high-flow oxygen devices such as an oxymizer or high humidity high-flow nasal cannula may be needed to maintain ade作者: OATH 時(shí)間: 2025-3-27 02:36 作者: BRIBE 時(shí)間: 2025-3-27 07:50
https://doi.org/10.1007/978-3-030-96213-5sensitivity pneumonitis (HP). It is also conceivable that the role of pharmacogenomics will evolve such that individualized or tailored therapies can be matched to patients’ genomic profile, thereby improving the efficacy of prescribed medications and reducing the likelihood of associated toxicities作者: 脫落 時(shí)間: 2025-3-27 11:37
Guide to Clinical Management of Idiopathic Pulmonary Fibrosis作者: 雪上輕舟飛過 時(shí)間: 2025-3-27 16:19 作者: FUSE 時(shí)間: 2025-3-27 20:56 作者: Aura231 時(shí)間: 2025-3-27 22:26
The Future for Idiopathic Pulmonary Fibrosis,sensitivity pneumonitis (HP). It is also conceivable that the role of pharmacogenomics will evolve such that individualized or tailored therapies can be matched to patients’ genomic profile, thereby improving the efficacy of prescribed medications and reducing the likelihood of associated toxicities作者: exigent 時(shí)間: 2025-3-28 05:11
2211-2758 d made his first contributions to, modal logic. However, the majority of the volume’s contributions are forward-looking, and produce new philosophical and technical insights by engaging with ideas tracing back to Kripke..978-3-031-57637-9978-3-031-57635-5Series ISSN 2211-2758 Series E-ISSN 2211-2766 作者: WATER 時(shí)間: 2025-3-28 09:49
Maria ?o?,Andrzej Zybertowiczs as described by Trace Transformation Theory (TTT), and consider the degree to which evidence related to the mechanistic basis of memory consolidation in rodents applies to complex human memory. We conclude that theories like TTT provide a new approach to thinking about consolidation as an ongoing 作者: 符合規(guī)定 時(shí)間: 2025-3-28 12:13 作者: 把手 時(shí)間: 2025-3-28 17:33
Molecular biology of the plant cell wall: searching for the genes that define structure, architecture and dynamicsthase, obviously function in cell wall bio genesis but do not contain signal peptides. Thus, it is likely that some 15% of the . genome is dedicated to cell wall biogenesis and modification. Of these, only small subsets have been characterized.作者: 藕床生厭倦 時(shí)間: 2025-3-28 21:19 作者: floodgate 時(shí)間: 2025-3-29 00:53 作者: 竊喜 時(shí)間: 2025-3-29 04:20
